Please use this identifier to cite or link to this item:
doi:10.22028/D291-38780 | Title: | Reply to RE: Should LHRH therapy be continued in patients receiving Abiraterone Acetate? |
| Author(s): | Ohlmann, Carsten-Henning |
| Language: | English |
| Publisher/Platform: | Springer Nature |
| Year of Publication: | 2022 |
| DDC notations: | 610 Medicine and health |
| Publikation type: | Other |
| DOI of the first publication: | 10.1038/s41391-022-00617-3 |
| URL of the first publication: | https://www.nature.com/articles/s41391-022-00617-3 |
| Link to this record: | urn:nbn:de:bsz:291--ds-387807 hdl:20.500.11880/34947 http://dx.doi.org/10.22028/D291-38780 |
| Date of registration: | 20-Jan-2023 |
| Faculty: | M - Medizinische Fakultät |
| Department: | M - Urologie und Kinderurologie |
| Professorship: | M - Keiner Professur zugeordnet |
| Collections: | SciDok - Der Wissenschaftsserver der Universität des Saarlandes |
Files for this record:
| File | Description | Size | Format | |
|---|---|---|---|---|
| s41391-022-00617-3.pdf | 282,35 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License
